Corticobasal Degeneration: Difference between revisions
(Starting a new page on corticobasal degeneration, want to load these files but have to step away for a minute.) |
(Ensuring my work is saved, finished introduction) |
||
| Line 5: | Line 5: | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}</div> | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}</div> | ||
== Clinically Relevant Anatomy | == Introduction == | ||
Corticobasal degeneration (CBD), sometimes called corticobasal ganglionic degeneration (CBDG) is a form of [[Parkinsonism]], more specifically a Parkinson-Plus Syndrome. Parkinson-Plus Syndromes are a group of neurodegenerative disorders that present with symptoms typical of [[Parkinson's Disease|Parkinson's Disease (PD)]] (bradykinesia, apraxia, resting tremor, rigidity, etc.), but may have additional cognitive deficits, dementia, cranial nerve involvement, and do not typically respond well to [[Levodopa - Parkinson's|levodopa]] intervention.<ref>Mark MH. [https://pubmed.ncbi.nlm.nih.gov/11532646/ Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration.] Neurol Clin. 2001;19(3):607-27</ref> <ref>Miyasaki JM. [https://pubmed.ncbi.nlm.nih.gov/27495200/ Treatment of Advanced Parkinson Disease and Related Disorders.] Continuum (Minneap Minn). 2016;22(4):1104-16</ref> | |||
== Clinically Relevant Anatomy == | |||
add text here relating to '''''clinically relevant''''' anatomy of the condition<br> | add text here relating to '''''clinically relevant''''' anatomy of the condition<br> | ||
== | == Pathophysiology == | ||
add text here relating to the mechanism of injury and/or pathology of the condition<br> | add text here relating to the mechanism of injury and/or pathology of the condition<br> | ||
Revision as of 04:47, 24 January 2024
Introduction[edit | edit source]
Corticobasal degeneration (CBD), sometimes called corticobasal ganglionic degeneration (CBDG) is a form of Parkinsonism, more specifically a Parkinson-Plus Syndrome. Parkinson-Plus Syndromes are a group of neurodegenerative disorders that present with symptoms typical of Parkinson's Disease (PD) (bradykinesia, apraxia, resting tremor, rigidity, etc.), but may have additional cognitive deficits, dementia, cranial nerve involvement, and do not typically respond well to levodopa intervention.[1] [2]
Clinically Relevant Anatomy[edit | edit source]
add text here relating to clinically relevant anatomy of the condition
Pathophysiology[edit | edit source]
add text here relating to the mechanism of injury and/or pathology of the condition
Clinical Presentation[edit | edit source]
add text here relating to the clinical presentation of the condition
Diagnostic Procedures[edit | edit source]
add text here relating to diagnostic tests for the condition
Outcome Measures[edit | edit source]
add links to outcome measures here (see Outcome Measures Database)
Management / Interventions
[edit | edit source]
add text here relating to management approaches to the condition
Differential Diagnosis
[edit | edit source]
add text here relating to the differential diagnosis of this condition
Resources
[edit | edit source]
add appropriate resources here
References[edit | edit source]
- ↑ Mark MH. Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration. Neurol Clin. 2001;19(3):607-27
- ↑ Miyasaki JM. Treatment of Advanced Parkinson Disease and Related Disorders. Continuum (Minneap Minn). 2016;22(4):1104-16
